Literature DB >> 1684737

Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients.

J Richner1, E P Ambinder, K Hoffmann, E J Feuer, G Bekesi.   

Abstract

Mononuclear cells from 12 normal controls (co), 10 advanced untreated (c1), and 6 advanced treated cancer patients (c2) have been isolated. The numbers of mononuclear cells bearing Leu1, Leu2, Leu3, Leu2/HLA-DR and LeuM3 were measured with a fluorescence-activated cell sorter. Only the quantity of helper T cells (Leu3) was decreased in cancer patients (co: 0.89, cl: 0.32, c2: 0.44 x 10(9)/l). Expression of all other markers, including activated suppressor T cells (Leu2/HLA-DR), did not differ significantly from the control. The proliferation of the lymphocytes was determined in a phytohemagglutinin-culture assay. The cancer groups showed a significantly decreased response (co: 95.8 x 10(9), cl: 28.7 x 10(9), c2: 25.7 x 10(9) cpm). These values correlated with the number of helper T cells but not with the suppressor T cells. Monocytes of cancer patients absorbed significantly more immunoglobulins than the monocytes of controls. The addition of indomethacin or isoprinosine to phytohemagglutinin-culture assay increased the proliferation of lymphocytes from both the cancer patients and normal controls.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684737     DOI: 10.1007/bf01741349

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  14 in total

1.  Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.

Authors:  M Wiranowska-Stewart; J W Hadden
Journal:  Int J Immunopharmacol       Date:  1986

Review 2.  Suppressor cell function in solid tumor cancer patients.

Authors:  J Von Roenn; J E Harris; D P Braun
Journal:  J Clin Oncol       Date:  1987-01       Impact factor: 44.544

3.  Human T lymphocytes stimulated by phytohaemagglutinin undergo a single round of cell division without a requirement for interleukin-2 or accessory cells.

Authors:  A R Mire-Sluis; R G Wickremasinghe; A V Hoffbrand; A M Timms; G E Francis
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

4.  Relationship of arachidonic acid metabolism to indomethacin-sensitive immunoregulatory function and lymphocyte PGE sensitivity in peripheral blood mononuclear cells of disseminated solid tumor cancer patients.

Authors:  D P Braum; J E Harris; M Rubenstein
Journal:  J Immunopharmacol       Date:  1984

5.  Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells.

Authors:  Z Steplewski; M D Lubeck; H Koprowski
Journal:  Science       Date:  1983-08-26       Impact factor: 47.728

6.  Isolation and functional characteristics of FcR+ and FcR- human monocyte subsets.

Authors:  M Zembala; W Uracz; I Ruggiero; B Mytar; J Pryjma
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

7.  Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.

Authors:  C U Ludwig; D Hartmann; R Landmann; M Wesp; G Rosenfelder; D Stucki; M Buser; J P Obrecht
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

8.  Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells.

Authors:  W J Tax; H W Willems; P P Reekers; P J Capel; R A Koene
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

9.  Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.

Authors:  H J Wanebo; R Pace; S Hargett; D Katz; J Sando
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

10.  Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes.

Authors:  S C Meuer; R E Hussey; A C Penta; K A Fitzgerald; B M Stadler; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

View more
  2 in total

1.  Lymphocyte proliferation is associated with gender, caregiving, and psychosocial variables in older adults.

Authors:  J M Scanlan; P P Vitaliano; J Zhang; M Savage; H D Ochs
Journal:  J Behav Med       Date:  2001-12

2.  Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.

Authors:  L Molto; M Alvarez-Mon; J Carballido; L Manzano; C Guillen; A Prieto; C Olivier; M Rodriguez-Zapata
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.